As the country awaits the UK's approval to the AstraZeneca-Oxford vaccine before giving nod for Emergency Use Authorisation to its Indian counterpart developed by Pune-based Serum Institute of India (SII), a top European drug official has claimed that the vaccine is not even ready for a conditional approval at the moment.